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 حتديد عوامل اخلطورة لالصابة بالعدوى املرتبطة بالرعاية الصحية
 اليت تسببها بكترييا أسينيتوباكرت بوماين املقاومة للكاربابنيم يف وحدة العناية
املركزة حلديثي الوالدة
اأمرية حممد �سلطان و وائل �سليم
abstract: Objectives: Acinetobacter baumannii is a causative pathogen of various healthcare-associated infec-
tions (HAIs) and is particularly prevalent in high-risk hospital settings. This study aimed to determine risk factors 
associated with HAIs caused by carbapenem-resistant A. baumannii (CRAB) in a neonatal intensive care unit 
(NICU). Methods: This prospective study was performed between January 2013 and June 2014 among NICU 
patients at the Mansoura University Children’s Hospital, Mansoura, Egypt. Neonates who developed HAIs due to 
CRAB were assigned to a case group, while those infected with carbapenem-sensitive A. baumannii (CSAB) were 
assigned to a control group. Results: Among the 124 neonates who developed A. baumannii-caused HAIs during 
the study period, 91 (73.4%) were caused by CRAB and 33 (26.6%) were caused by CSAB. Prematurity, premature 
rupture of the membranes (PROM), a previous stay in another hospital, prolonged NICU stay, the presence of 
invasive devices, previous exposure to carbapenems or aminoglycosides and prolonged antibiotic therapy before 
infection were significantly associated with CRAB-caused HAIs. A multivariate logistic regression analysis identified 
prematurity (adjusted odds ratio [aOR] = 25.3; P <0.01), mechanical ventilation (aOR = 18.9; P <0.01) and the previous 
use of carbapenems (aOR = 124.7; P <0.01) or aminoglycosides (aOR = 22.6; P = 0.04) to be independent risk factors 
for CRAB infections. Conclusion: Various risk factors were significantly associated with CRAB-caused HAIs among 
the studied NICU patients.
Keywords: Healthcare Associated Infections; Antimicrobial Drug Resistance; Carbapenem Antibiotics; Acineto-
bacter baumannii; Neonatal Intensive Care Units; Egypt.
امللخ�ص: الهدف: تعترب بكترييا اأ�سينيتوباكرت بوماين اأحد م�سببات العدوى املرتبطة بالرعاية ال�سحية. و حيث اأنها تتواجد ب�سكل خا�ض 
يف مناطق الرعاية ال�سحية ذات اخلطورة العالية فقد هدفت هذه الدرا�سة اىل حتديد عوامل اخلطورة لال�سابة بالعدوى املرتبطة بالرعاية 
ال�سحية التي ت�سببها بكترييا اأ�سينيتوباكرت بوماين املقاومة للكاربابنيم يف وحدة العناية املركزة حلديثي الوالدة. الطريقة: اأجريت هذه 
الوالدة مب�ست�سفى االأطفال اجلامعى، املن�سورة،  العناية املركزة حلديثي  2014 يف وحدة  2013 ويونيو  الدرا�سة اال�ستطالعية بني يناير 
م�رص. مت ادراج املر�سى امل�سابني بالعدوى املرتبطة بالرعاية ال�سحية الناجتة عن بكترييا اأ�سينيتوباكرت بوماين املقاومة للكاربابنيم 
يف جمموعة الدرا�سة يف حني مت ادراج املر�سى امل�سابني بالعدوى املرتبطة بالرعاية ال�سحية الناجتة عن بكترييا اأ�سينيتوباكرت بوماين 
الناجتة عن  ال�سحية  124 مري�سا م�سابا بالعدوى املرتبطة بالرعاية  النتائج: مت ر�سد  ال�سابطة.  للكاربابنيم يف املجموعة  احل�سا�سة 
الناجتة عن  ال�سحية  الدرا�سة. و قد كان عدد املر�سى امل�سابني بالعدوى املرتبطة بالرعاية  اأ�سينيتوباكرت بوماين خالل فرتة  بكترييا 
املرتبطة  بالعدوى  امل�سابني  املر�سى  عدد  كان  بينما   )73.4%( مري�سا   91 هو  للكاربابنيم  املقاومة  بوماين  اأ�سينيتوباكرت  بكترييا 
)%26.6(. وقد �سملت عوامل اخلطورة  33 مري�سا  اأ�سينيتوباكرت بوماين احل�سا�سة للكاربابنيم هو  بالرعاية ال�سحية الناجتة عن بكترييا 
اأ�سينيتوباكرت بوماين املقاومة للكاربابنيم كل من االأطفال اخلدج،  لال�سابة بالعدوى املرتبطة بالرعاية ال�سحية التي ت�سببها بكترييا 
والتمزق املبكر لالأغ�سية املحيطة باجلنني، واالقامة يف م�ست�سفى اآخر، واالإقامة لفرتات طويلة يف وحدة العناية املركزة حلديثي الوالدة، 
اأمينوغليكوزيد�ض والعالج بامل�سادات احليوية لفرتات طويلة قبل اال�سابة  اأو  للكاربابنيم  ال�سابق  والتعر�ض  اجتياحية،  اأجهزة  ووجود 
 ،)P >0.01 25.3؛ = )aOR( بالعدوى. وقد بني االنحدار اللوج�ستي متعدد املتغريات اأن كل من االأطفال اخلدج )ن�سبة االأرجحية املعدلة
املعدلة  االأرجحية  )ن�سبة  للكاربابنيم  ال�سابق  واال�ستخدام   )P  >0.01 18.9؛   =  )aOR( املعدلة  االأرجحية  ))ن�سبة  امليكانيكية  والتهوية 
P( ميثلون عوامل خطورة م�ستقلة  22.6؛ 0.04 =   =  )aOR( االأرجحية املعدلة )ن�سبة  اأمينوغليكوزيدز  اأو   )P  >0.01 124.7؛   = )aOR(
اأنه  اأ�سينيتوباكرت بوماين املقاومة للكاربابنيم. اخلال�صة: لقد تبني  لالإ�سابة بالعدوى املرتبطة بالرعاية ال�سحية التي ت�سببها بكترييا 
املقاومة  بوماين  اأ�سينيتوباكرت  بكترييا  ت�سببها  التي  ال�سحية  بالرعاية  املتعلقة  بالعدوى  باالإ�سابة  مرتبطة  يوجد عدة عوامل خطورة 
للكاربابنيم يف وحدة العناية املركزة حلديثي الوالدة.
الكلمات املفتاحية: العدوى املرتبطة بالرعاية ال�سحية؛ امليكروبات املقاومة للم�سادات احليوية؛ م�سادات الكاربابنيم؛ بكترييا اأ�سينيتوباكرت 
بوماين؛ وحدة العناية املركزة حلديثي الوالدة؛ م�رص.
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Healthcare-associated infections (hais) are infections contracted in various health-care settings and are well known to increase 
morbidity, mortality, length of hospital stay and the 
cost of medical care.1 Intensive care units (ICUs), 
including neonatal ICUs (NICUs), constitute high-risk 
areas for HAIs as admitted patients are usually critically 
ill and commonly undergo invasive procedures.2 Acine-
tobacter baumannii is a major causative pathogen of 
various HAIs, such as bloodstream infections and 
pneumonia, particularly in high-risk settings such as 
ICUs. Unfortunately, recent studies have reported a 
steady increase in the prevalence of carbapenem-
resistant A. baumannii (CRAB) strains isolated from 
patients with HAIs.3–5 This study therefore aimed to 
determine risk factors for the development of CRAB-
caused HAIs among patients in a NICU in Egypt.
Methods
This prospective single-centre study was conducted 
between January 2013 and June 2014 in the NICU of 
the Mansoura University Children’s Hospital, Man- 
soura, Egypt. All patients who developed A. baumannii- 
caused HAIs of any type following their admission 
to the NICU were included in the study. The identi-
fication of A. baumannii strains was performed using 
colony morphology, microscopic examination and 
biochemical tests. The API® 20 NE identification 
system (bioMérieux Inc, St. Louis, Missouri, USA) was 
used to confirm the diagnosis of an A. baumannii-
caused infection. Patients who developed HAIs with 
A. baumannii isolates showing resistance to imipenem 
or meropenem were assigned to a case group while those 
with isolates sensitive to imipenem and meropenem 
were assigned to a control group. The sensitivity 
patterns of the isolated A. baumannii strains were 
detected using the disc diffusion method. All results 
were interpreted using the guidelines of the Clinical 
and Laboratory Standards Institute.6
Surveillance procedures conducted for patients 
with different types of HAIs were performed acc-
ording to the definitions, elements and criteria of the 
Centers for Disease Control and Prevention.7 Infections 
developing during the first two calendar days of hosp-
ital stay were deemed to have been present upon 
admission, while infections developing on or after the 
third calendar day of hospital stay were considered 
HAIs. Information regarding the HAI was collected 
by reviewing the patients’ medical records and their 
clinical and laboratory findings. Possible risk factors 
were documented for each patient, including pre-
maturity (<37 gestational weeks); low birth weight 
(<2,500 g); premature rupture of the membranes; age; 
gender; previous stay in another hospital; length of 
NICU stay prior to infection; the presence of an inv-
asive device; duration of antibiotic therapy before the 
HAI; and previous antibiotic exposure. The latter risk 
factor was considered present only in cases wherein 
systemic antibiotics were administered for a minimum 
of 24 hours within the 14-day period prior to the 
isolation of the A. baumannii strain. In terms of patient 
outcome, HAI-related mortality was defined as death 
within 30 days of developing the infection.
Statistical analysis was performed using the Stat- 
istical Package for the Social Sciences (SPSS), Version 
22.0 (IBM Corp, Armonk, New York, USA). Nonpara-
metric demographic and clinical parameters were com-
pared using the Mann-Whitney U test and presented 
as medians and ranges. Categorical variables were 
compared using the Chi-squared test and presented 
as percentages. A multivariate analysis was performed 
using binary logistic regression to assess independent 
risk factors for CRAB-caused HAIs. Differences were 
considered statistically significant at P ≤0.05.
Advances in Knowledge
- The current study identified significant risk factors associated with healthcare-associated infections (HAIs) caused by carbapenem-
resistant Acinetobacter baumannii (CRAB) among patients in a neonatal intensive care unit (NICU) in Egypt. 
- Significant risk factors included prematurity, premature rupture of the membranes, a previous stay in another hospital, prolonged 
NICU stay, the presence of an invasive device (i.e. an umbilical catheter, urinary catheter or mechanical ventilator), previous exposure 
to carbapenems or aminoglycosides and prolonged antibiotic therapy prior to the infection.
Application to Patient Care
- The findings of this study may be utilised by NICU staff to decrease risk factors associated with carbapenem resistance among Egyptian 
neonates.
Table 1: Healthcare-associated infections caused by carb-
apenem-resistant or -sensitive Acinetobacter baumannii 
in a neonatal intensive care unit in Egypt (N = 124)





Blood stream 65 (71.4) 22 (66.7)
Pneumonia 17 (18.7) 7 (21.2)
Urinary tract 7 (7.7) 3 (9.1)
Other 2 (2.2) 1 (3)
CRAB = carbapenem-resistant Acinetobacter baumannii; 
CSAB = carbapenem-sensitive A. baumannii.
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This study received ethical approval from the 
Institutional Review Board of the Faculty of Medicine, 
Mansoura University (#R/17.10.10). Informed consent 
was obtained from a parent or guardian of all of the 
patients included in the study.
Results
During the study period, 124 neonates in the NICU 
developed HAIs caused by A. baumannii. Of these, 91 
infections (73.4%) were caused by CRAB and 33 (26.6%) 
were caused by carbapenem-sensitive A. baumannii 
(CSAB). In both groups, bloodstream infections were 
most common [Table 1]. There was no statistically 
significant difference between the groups in terms 
of sites of infection. Prematurity, premature rupture 
of the membranes, a previous stay in another hospital 
and prolonged NICU stay prior to infection were iden- 
tified as significant risk factors for CRAB-caused HAIs 
(P <0.05 each). Moreover, the presence of an umbilical 
catheter, urinary catheter or mechanical ventilator, 
previous exposure to carbapenems or aminoglycosides 
and prolonged antibiotic therapy were also significant 
risk factors (P <0.05 each). Prematurity (adjusted odds 
ratio [aOR] = 25.3; P <0.01), mechanical ventilation 
(aOR = 18.9; P <0.01) and the previous use of 
carbapenems (aOR = 124.7; P <0.01) or aminoglycosides 
(aOR = 22.6; P = 0.04) were independent risk factors for 
CRAB infections [Table 2].
A total of 70 (76.9%) patients with CRAB infect-
ions and eight (24.2%) patients with CSAB infections 
died; this difference in mortality rate between the two 
groups was statistically significant (P = 0.01). Signif-
icant mortality-related risk factors among patients with 
Table 2: Risk factors associated with healthcare-associated infections caused by carbapenem-resistant or -sensitive 
Acinetobacter baumannii in a neonatal intensive care unit in Egypt (N = 124)







P value aOR (95% CI) P value
Postnatal age in days
<7 45 (49.5) 18 (54.5) 0.65
≥7 46 (50.5) 15 (45.5) 0.35
Male gender 39 (42.9) 16 (48.5) 0.78
Prematurity 54 (59.3) 8 (24.2) 0.03* 25.3 (8.4–784.8) <0.01*
LBW 29 (31.9) 10 (30.3) 0.88
PROM 42 (46.2) 5 (15.2) 0.01*
PSAH 17 (18.7) 2 (6.1) 0.03*
Median length of stay in the NICU 
prior to HAI (range)
10 (6.4–15.2) 4 (2.6–7.9) 0.04*
Presence of an invasive device
Umbilical catheter 70 (76.9) 11 (33.3) 0.04*
PPCL 10 (11) 5 (15.2) 0.85
Urinary catheter 66 (72.5) 7 (21.2) <0.01*
MV 72 (79.1) 9 (27.3) <0.01* 18.9 (3.5–1,135.1) <0.01*
Previous antibiotic exposure
Carbapenems 55 (60.4) 5 (15.2) <0.01* 124.7 (45.2–588.1) <0.01*
Cephalosporins 24 (26.4) 6 (18.2) 0.07
Aminoglycosides 42 (46.2) 4 (12.1) 0.02* 22.6 (1.1–864.9) 0.04*
Vancomycin 30 (33) 12 (36.4) 0.79
Median duration of antibiotic 
therapy before HAI in days (range)
8 (5.7–10.4) 2 (1.2–4.6) <0.05*
CRAB = carbapenem-resistant Acinetobacter baumannii; CSAB = carbapenem-sensitive A. baumannii; aOR = adjusted odds ratio; CI = confidence 
interval; LBW = low birth weight; PROM = premature rupture of the membranes; PSAH = previous stay in another hospital; NICU = neonatal 
intensive care unit; HAI = healthcare-associated infection; PPCL = peripheral percutaneous central line; MV = mechanical ventilator.
*Considered statistically significant at P ≤0.05.
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CRAB infections included prolonged NICU stay, the 
presence of an umbilical catheter or mechanical vent-
ilator and the previous administration of carbapenems 
(P <0.02 each). Independent risk factors for mortality 
were mechanical ventilation (aOR = 17.2; P = 0.04) and 
the previous use of carbapenems (aOR = 79.1; P <0.01) 
[Table 3]. Isolates from both the CRAB and CSAB 
groups demonstrated high resistance rates to all anti-
microbials except for tigecycline, with no significant 
differences between the two groups [Table 4].
Discussion
The ability to survive in a hospital environment has 
resulted in a high incidence of HAIs attributed to 
A. baumannii; furthermore, the organism rapidly deve-
lops resistance to a broad range of antibiotic classes.8 
Previous research has indicated that the incidence of 
A. baumannii-resistant strains is increasing all over the 
world.3–5 According to surveillance data in the USA, 
carbapenem resistance increased from 5.2% to 40.8% 
between 1999 and 2010.9 Similarly, in Europe, surv-
eillance data from 2012 indicated that 68.8% of 
A. baumannii strains isolated from ICUs were resistant 
to carbapenems.10 These findings support those of the 
present study which indicated a high rate of carba-
penem resistance in the studied Egyptian NICU.
In terms of invasive procedures, mechanical vent- 
ilation was the only independent risk factor for CRAB-
caused HAIs in the current study. Previous studies have 
reported similar findings.11,12 Mechanical ventilation is 
indicated for neonates in cases of respiratory distress, 
Table 3: Mortality-related risk factors among patients with health-care-associated infections caused by carbapenem-
resistant or -sensitive Acinetobacter baumannii in a neonatal intensive care unit in Egypt 
(N = 124)







P value aOR (95% CI) P value
Postnatal age in days
<7 32 (45.7) 3 (37.5) 0.38
≥7 38 (54.3) 5 (62.5) 0.61
Male gender 34 (48.6) 4 (50) 0.80
Prematurity 33 (47.1) 3 (37.5) 0.21
LBW 25 (35.7) 3 (37.5) 0.89
PROM 32 (45.7) 4 (50) 0.42
PSAH 10 (14.3) 1 (12.5) 0.67
Median length of NICU stay prior to 
HAI (range)
12 (8.3–15.2) 5.4 (3.6–7.9) 0.02*
Presence of an invasive device
Umbilical catheter 55 (78.6) 1 (12.5) <0.01*
PPCL 8 (11.4) 1 (12.5) 0.82
Urinary catheter 54 (77.1) 6 (75) 0.87
MV 57 (81.4) 2 (25) 0.02* 17.2 (2.1–129.2) 0.04*
Previous antibiotic exposure
Carbapenems 53 (75.7) 1 (12.5) <0.01* 79.1 (32.7–278.9) <0.01*
Cephalosporins 18 (25.7) 2 (25) 0.94
Aminoglycosides 20 (28.6) 2 (25) 0.76
Vancomycin 25 (35.7) 3 (37.5) 0.65
Median days of antibiotic therapy 
before HAI in days (range)
5.1 (3.8–8.7) 3.2 (2.1–3.5) 0.09
CRAB = carbapenem-resistant Acinetobacter baumannii; CSAB = carbapenem-sensitive A. baumannii; aOR = adjusted odds ratio; CI = confidence 
interval; LBW = low birth weight; PROM = premature rupture of the membranes; PSAH = previous stay in another hospital; NICU = neonatal 
intensive care unit; HAI = healthcare-associated infection; PPCL = peripheral percutaneous central line; MV = mechanical ventilator.
*Considered statistically significant at P ≤0.05.
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hypoxaemia or hypercapnia; however, organisms present 
in the hospital environment frequently attach to the 
ventilator tube and form a biofilm which is associated 
with an increased risk of antibiotic resistance.13 Further- 
more, ventilated critically-ill neonates often undergo 
endotracheal intubation which can interrupt immunity 
barriers.14 Therefore, the incidence of HAIs may poten-
tially be reduced by encouraging the use of noninvasive 
ventilation among neonates, such as nasal continuous 
positive pressure ventilation.15 
In the current study, a previous stay in another 
hospital and prolonged NICU stay prior to infection 
were found to constitute significant risk factors for 
subsequent CRAB infections. This may be attributable 
to prolonged exposure to organisms present in the 
hospital environment and the extended use of anti-
biotics that aid in the development of antimicrobial 
resistance.11,12 Rosa et al. reported that exposure to a 
contaminated hospital environment increased the risk 
of acquisition of CRAB isolates.16 Baran et al. indicated 
that patients admitted to the ICU had a three-fold 
higher risk of CRAB infections.17 Playford et al. also 
observed an association between prolonged ICU stay 
and CRAB infection.18 Unfortunately, the nature of 
multidrug-resistant microorganisms, including A. bau- 
mannii, in ICUs is endemic. In addition, the likelihood 
of antimicrobial therapy increases with the duration of 
ICU stay, thus leading to the colonisation of resistant 
strains of bacteria.
Previous exposure to carbapenems was another 
independent risk factor for HAIs caused by CRAB in 
the present study. Sheng et al. also noted that patients 
with CRAB infections were significantly more likely 
to have been exposed to carbapenems.19 Such findings 
emphasise the need for the judicious use of carba-
penem antibiotics, which should remain a last resort 
in the treatment of serious infections so as to control 
the development of carbapenem-resistant microbes. 
As with carbapenems, previous exposure to aminoglyco-
sides was another independent risk factor for CRAB 
infections in the current study. Chen et al. also 
observed prior exposure to aminoglycosides such as 
amikacin to be a risk factor for CRAB.20 Treating 
physicians should therefore consider these findings 
before prescribing aminoglycosides to ICU patients.
In the current study, CRAB isolates showed high 
resistance rates to other antibiotics. Similar findings 
were reported by Falagas et al. among pandrug-resistant 
A. baumannii infection cases.21 Infections caused by 
multidrug-resistant pathogens have many adverse out- 
comes, including prolonged hospital stay, higher treat- 
ment costs and increased mortality rates.22 The treatment 
of patients suffering from infections caused by such 
strains is challenging. Adequate knowledge of local A. 
baumannii resistance patterns is a fundamental element 
to a successful therapeutic approach.23 In terms of mort- 
ality, the presence of an umbilical catheter or mechanical 
ventilator, prolonged stay in the NICU and the 
previous administration of carbapenems resulted in 
significantly increased mortality among patients with 
HAIs caused by CRAB. Similar results were reported 
by Djordjevic et al. among adult patients admitted to a 
medical-surgical ICU.24
This study is subject to certain limitations. 
Generally, NICUs in developing countries such as 
Egypt usually have low staff-to-patient ratios, often 
resulting in a lack of essential infection control pre-
cautions like thorough hand hygiene and aseptic 
procedures. Under these conditions, resistant bacteria 
can more easily spread between patients, resulting in 
more colonised and infected cases compared to adeq-
uately staffed units. In addition, the low number of 
patients in the control group in comparison to the case 
group resulted in a wide confidence interval, weak-
ening the findings of the present study.
Conclusion
This study found that prematurity, premature rupture 
of the membranes, a previous stay in another hosp- 
ital, prolonged NICU stay, the presence of an invasive 
device, previous exposure to carbapenems or amino-
glycosides and prolonged antibiotic therapy were signif- 
Table 4: Antimicrobial resistance of carbapenem-resistant 
and -sensitive Acinetobacter baumannii isolates in a 
neonatal intensive care unit in Egypt (N = 124)












80 (87.9) 25 (75.8) 0.68
Cefotaxime 
(30 μg/mL)
91 (100) 33 (100) >0.99
Cefepime 
(30 μg/mL)
71 (78) 26 (78.8) 0.98
Gentamicin 
(10 μg/mL)
78 (85.7) 27 (81.8) 0.87
Amikacin 
(30 μg/mL)
87 (95.6) 29 (87.9) 0.69
Ciprofloxacin 
(5 μg/mL)*
86 (94.5) 27 (81.8) 0.85
Tigecycline 
(15 μg/mL)
9 (9.9) 4 (12.1) 0.58
CRAB = carbapenem-resistant Acinetobacter baumannii; CSAB = carb-
apenem-sensitive A. baumannii. *Not recommended for use in neonates.
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icantly associated with CRAB-caused HAIs in an NICU 
in Egypt. Moreover, prematurity, mechanical ventilation 
and previous exposure to carbapenems or aminoglyco-
sides were independent risk factors for the development 
of HAIs caused by CRAB.
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